Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients. TOKYO, Feb. 13, 2025 /PRNewswire/ -- Restore...
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003
SUZHOU, China, Feb. 13, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 biparatopic antibody-drug...
Illuccix® Approved in the United Kingdom
MELBOURNE, Australia, Feb. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the...
Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal
Confirms the utility of the 10 mg daily oral dose of Xanamem being studied in late-stage clinical trials in Alzheimer's disease and major depressive disorder SYDNEY, Feb. 12, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that...
IFS named a Leader in two IDC MarketScape 2024-2025 Vendor Assessments: Manufacturing ERP and Remanufacturing Management Software
LONDON, Feb. 12, 2025 /PRNewswire/ -- IFS, the leading enterprise cloud and Industrial AI software provider, announces that it has been positioned as a Leader in two IDC MarketScape reports: the IDC MarketScape: Worldwide SaaS and Cloud-Enabled...
ZIWIG ENDOTEST®: FAST-TRACK REIMBURSEMENT FOR 25 000 PATIENTS FOR FIRST SALIVA TEST TO DIAGNOSE ENDOMETRIOSIS IN 80 MEDICAL CENTERS IN FRANCE
LYON, France, Feb. 11, 2025 /PRNewswire/ -- Ziwig, a French biotech company committed to advancing women's health, announces the fast-track reimbursement of Ziwig Endotest® - the first saliva diagnostic test for endometriosis- for 25 000 patients...
Trip.com Group Announces Changes in Board Composition
SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours, and...
Cisco Redefines Data Center Architecture with New Smart Switches, Embedding Services Directly into the Network
New switches with embedded AMD Pensando DPUs are highly adaptive and scalable for AI demands—enabling enterprises to add services as needs evolve News Summary Cisco announces the Cisco N9300 Series Smart Switches with a new class of intelligent...
Citi Foundation Announces 2025 Global Innovation Challenge for Nonprofits Accelerating Youth Employability
50 community organizations to receive a collective $25 million in catalytic funding, building on over a decade of Citi Foundation investment in youth. NEW YORK, Feb. 11, 2025 /PRNewswire/ -- The Citi Foundation today issued a Request for Proposals...
Origin Agritech Reports 24.6% Revenue Growth and Key Technological Milestones in Fiscal Year 2024
Announces Filing of Annual Report on Form 20-F for Fiscal Year 2024 BEIJING, Feb. 11, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced financial...